Home | Contact Us | Log In
(888) 789-6604
Report Stack
Advanced search
Account Detail 0 items in basket
Order History Total $
Saved Searches View Basket basket
 
Advanced search:
Enter Search Keyword
 
Filter your search by:
Industry
Country
Publish date
Search By Price Range
From:$
    To:$
 
GBI Research
Results 1-10 of 261  1 2 3 >  Last › Sort By :
Title Date Price
Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2023 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth
By GBI Research
"Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2023 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth Summary Diabetes me ...Read More
Oct 2017 $4995.00
Frontier Pharma:Cancer Immunotherapies - First-in-Class Pipeline Dominated by Immunomodulators and PD-1 Like Targets
By GBI Research
Description Cancer is a group of diseases that are defined by abnormal cell growth, local tissue invasion and eventual migration to other parts of the body. The diseases are driven by the accumulati ...Read More
Sep 2017 $6995.00
Global Respiratory Drugs Market to 2023 - A Changing Therapeutic Landscape as Key Patents Expire and Biologics, Targeted Therapies and CFTR Modulators for Asthma and Cystic Fibrosis Treatment Emerge as Market Growth Drivers
By GBI Research
Global Respiratory Drugs Market to 2023 - A Changing Therapeutic Landscape as Key Patents Expire and Biologics, Targeted Therapies and CFTR Modulators for Asthma and Cystic Fibrosis Treatment Emerge a ...Read More
Sep 2017 $4995.00
Frontier Pharma: Cancer Immunotherapies - First-in-Class Pipeline Dominated by Immunomodulators and PD-1 Like Targets
By GBI Research
Frontier Pharma: Cancer Immunotherapies - First-in-Class Pipeline Dominated by Immunomodulators and PD-1 Like TargetsSummaryCancer is a group of diseases that are defined by abnormal cell growth, loca ...Read More
Sep 2017 $6995.00
Back to Report Store Home Frontier Pharma: Hematological Disorders - Iron Regulators and Immune Response Targeted Programs Within Anemias and other Red Blood Cell Disorders Hold Potential to Transform Therapy Area with Significant Unmet Need
By GBI Research
The hematological disorders therapy area encompasses non-malignant disorders of the blood such as anemia, sickle cell disease, neutropenia and hemophilia. These diseases can be grouped into the three ...Read More
Aug 2017 $6995.00
Genetic Ophthalmology Disorders Drug Development Pipeline Review, 2017
By GBI Research
Genetic Ophthalmology Disorders Drug Development Pipeline Review, 2017SummaryThis report provides an overview of the pipeline landscape for genetic ophthalmological disorders. The report provides comp ...Read More
Aug 2017 $3995.00
Hepatitis Drug Development Pipeline Review, 2017
By GBI Research
Hepatitis Drug Development Pipeline Review, 2017SummaryThis report provides an overview of the hepatitis pipeline landscape. The report provides comprehensive information on the therapeutics under dev ...Read More
Aug 2017 $3995.00
Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
By GBI Research
Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017SummaryThis report provides an overview of the pipeline landscape for neuropsychiatric disorders. The report provides comprehens ...Read More
Aug 2017 $3995.00
Frontier Pharma: Hematological Disorders - Iron Regulators and Immune Response Targeted Programs Within Anemias and other Red Blood Cell Disorders Hold Potential to Transform Therapy Area with Significant Unmet Need
By GBI Research
Frontier Pharma: Hematological Disorders - Iron Regulators and Immune Response Targeted Programs Within Anemias and other Red Blood Cell Disorders Hold Potential to Transform Therapy Area with Signifi ...Read More
Aug 2017 $6995.00
Global Ophthalmology Drugs Market to 2023 - Angiogenesis Inhibitors in wAMD Set to Retain High Market Share, While Expansive Pipeline for Glaucoma Leads the Research Landscape
By GBI Research
Global Ophthalmology Drugs Market to 2023 - Angiogenesis Inhibitors in wAMD Set to Retain High Market Share, While Expansive Pipeline for Glaucoma Leads the Research LandscapeSummaryOphthalmology is a ...Read More
Aug 2017 $4995.00
Results 1-10 of 261  1 2 3 >  Last ›

Companies


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Countries


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z